Evidence map›Paper›PMID 25962591›Full record

ArticleGenome biology2015

Erratum to: Modeling precision treatment of breast cancer.

Anneleen Daemen, Obi L Griffith, Laura M Heiser, Nicholas J Wang, Oana M Enache, Zachary Sanborn, Francois Pepin, Steffen Durinck, James E Korkola, Malachi Griffith and 17 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Genome biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. [Artificial intelligence empowers laboratory medicine in Industry 4.0].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Anneleen DaemenDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. daemena@gene.com.
Obi L GriffithDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. ogriffit@genome.wustl.edu.
Laura M HeiserDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. heiserl@ohsu.edu.
Nicholas J WangDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. wangnic@ohsu.edu.
Oana M EnacheDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. oenache@berkeley.edu.
Zachary SanbornFive3 genomics, 101 Cooper St, Santa Cruz, CA, 95060, USA. zack@five3genomics.com.
Francois PepinDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. francois.pepin@sequenta.com.
Steffen DurinckDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. sdurinck@gmail.com.
James E KorkolaDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. korkola@ohsu.edu.
Malachi GriffithThe Genome Institute, Washington University School of Medicine, St Louis, MO, 63105, USA. mgriffit@genome.wustl.edu.
Joe S HurSamsung Electronics Headquarters, Seocho-gu, Seoul, 137-857, Korea. joe.hur@samsung.com.
Nam HuhEmerging Technology Research Center, Samsung Advanced Institute of Technology, Kyunggi-do, 446-712, Korea. namhuh@samsung.com.
Jongsuk ChungEmerging Technology Research Center, Samsung Advanced Institute of Technology, Kyunggi-do, 446-712, Korea. doogie.chung@samsung.com.
Leslie CopeDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. Lcope1@jhmi.edu.
Mary Jo FacklerDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. facklma@jhmi.edu.
Christopher UmbrichtDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. cumbrich@jhmi.edu.
Saraswati SukumarDepartment of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. saras@jhmi.edu.
Pankaj SethDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. pseth@bidmc.harvard.edu.
Vikas P SukhatmeDepartment of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. vsukhatm@bidmc.harvard.edu.
Lakshmi R JakkulaDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. lrjk@hotmail.com.
Yiling LuDepartment of Systems Biology, MD Anderson Cancer Center, Houston, TX, 77030, USA. yilinglu@mdanderson.org.
Gordon B MillsDepartment of Systems Biology, MD Anderson Cancer Center, Houston, TX, 77030, USA. gmills@mdanderson.org.
Raymond J ChoDepartment of Dermatology, University of California, San Francisco, CA, 94115, USA. choR@derm.ucsf.edu.
Eric A CollissonDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. Eric.Collisson@ucsf.edu.
Laura J Van't VeerLaboratory Medicine, University of California San Francisco, San Francisco, CA, 94115, USA. VantveerL@cc.ucsf.edu.
Paul T SpellmanDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. spellmap@ohsu.edu.
Joe W GrayDepartment of Cancer & DNA Damage Responses, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, 94720, USA. grayjo@ohsu.edu.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
6 · The paper itself

Abstract

During the type-setting of the final version of the article [1] some of the additional files were swapped. The correct files are republished in this Erratum.

Identifiers

PMID25962591
PMCPMC4426644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.